Jonathan Belsey
Overview
Explore the profile of Jonathan Belsey including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
252
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Su W, Stricherz M, Martin A, Belsey J, Kemadjou E, DeAngelo D
Am J Hematol
. 2025 Feb;
PMID: 39945071
Adults with acute lymphoblastic leukemia/lymphoblastic lymphoma (ALL/LBL) have poorer outcomes than pediatric patients. The aim of this systematic literature review and meta-analysis was to compare asparaginase (ASP)-containing pediatric-inspired regimens (PIRs)...
2.
Belsey J, Weglarz J, Scherer M, Pluym N, Polosa R
Heliyon
. 2024 Nov;
10(21):e39695.
PMID: 39553606
Background: The substitution of combustible cigarettes (CC) with non-combustible nicotine alternatives, such as e-cigarettes (EC), significantly lowers exposure to harmful chemicals. However, many individuals who use ECs continue smoking CCs,...
3.
Del Giudice F, Vestri A, Fegatelli D, Husch T, Belsey J, Nair R, et al.
BJU Int
. 2024 Oct;
135(2):346-354.
PMID: 39397266
Background: A second transurethral resection of bladder tumour (Re-TURBT) is recommended by European Association of Urology (EAU) Guidelines on non-muscle-invasive bladder cancers (NMIBCs) due to the risk of understaging and/or...
4.
Chaudhuri K, Bergmann L, Belsey J, Boodhna T, Leoncini E
J Med Econ
. 2024 Sep;
27(1):1267-1278.
PMID: 39254803
Aims: In advanced Parkinson's disease (aPD), adequate 24-hour control of OFF-time may not be achievable using oral/transdermal therapies. Clinical trials of foslevodopa/foscarbidopa (LDp/CDP) demonstrate meaningful reductions in OFF-time and OFF-related...
5.
Polosa R, Pluym N, Scherer M, Belsey J, Russell C, Caponnetto P, et al.
Front Public Health
. 2024 Apr;
12:1348389.
PMID: 38584934
Introduction: Many smokers who use e-cigarettes (ECs) to quit continue smoking alongside vaping. The impact on health among individuals who simultaneously smoke conventional cigarettes (CCs) and use ECs remains unclear....
6.
Cordeiro M, Denis P, Astarita C, Belsey J, Rivas M, Garcia-Feijoo J
Curr Med Res Opin
. 2024 Feb;
40(4):647-655.
PMID: 38410906
Objective: To evaluate the prevalence of comorbidities that may limit or prevent adherence to topical ocular hypotensive therapy in patients with open-angle glaucoma (OAG). Methods: The UK Clinical Practice Research...
7.
Krysinski A, Russo C, Campagna D, Di Pino A, John S, Belsey J, et al.
Intern Emerg Med
. 2023 Nov;
19(2):321-332.
PMID: 37999870
Stopping smoking is crucial for public health and especially for individuals with diabetes. Combustion-free nicotine alternatives like e-cigarettes and heated tobacco products are increasingly being used as substitutes for conventional...
8.
Belsey J
J Med Econ
. 2023 Oct;
26(1):1398-1406.
PMID: 37800535
Aims: French guidelines for the management of non-muscle-invasive bladder cancer recommend that blue-light cystoscopy should be used in patients where the risk of missing residual tumor is highest. Despite evidence...
9.
Reddy D, van Son M, Peters M, Bertoncelli Tanaka M, Dudderidge T, Cullen E, et al.
J Med Econ
. 2023 Sep;
26(1):1099-1107.
PMID: 37656223
Aims: Focal therapy treats individual areas of tumour in non-metastatic prostate cancer in patients unsuitable for active surveillance. The aim of this work was to evaluate the cost-effectiveness of focal...
10.
Chaudhuri K, Hand A, Obam F, Belsey J
J Med Econ
. 2022 May;
25(1):774-782.
PMID: 35593687
Aims: The Parkinson's KinetiGraph (PKG) is a wrist-worn movement recording system that collates continuous, objective, data during daily activities in people with Parkinson's disease (PD) providing a report for clinicians....